Trade & Channel Strategies 2024: Patient-Centric 3.0 — How Direct-to-Patient is the New Commercialization Model

Recent Press Releases

• EVERSANA Earns Prestigious Designations from Leading Organizations for Specialty Pharmacy Operations Excellence, Superior Care for Rare Disease Patients
• ConTIPI Medical & EVERSANA Announce U.S. Commercial Launch of Non-Surgical Medical Device ProVate for Women With Pelvic Organ Prolapse
• EVERSANA Named a Great Place to Work for Six Consecutive Years; Now Certified Across Nine Countries
• EVERSANA Transforms Pharmacovigilance & Drug Safety Industry with Oracle Collaboration, New Global Patient Support Model
• EVERSANA Expands Safety Case Management Capabilities with Oracle